Riskpilot← Back to searchSign inGet full accessEmmer Medical AB
ABActiveOrg 5594178203Birger Jarlsgatan 125 Lgh 1302General medical practice activities · NACE 8621Est. 20232 employees
Revenue 2025
SEK 412K
-2% vs 2024
EBITDA margin
79.6%
+20% vs 2024
Equity ratio
42.0%
Financial strength
Net profit 2025
SEK 261K
+19% vs 2024
| Revenue | SEK 412K | -2% |
| EBITDA | SEK 328K | +20% |
| Net profit | SEK 261K | +19% |
| Total assets | SEK 681K | +60% |
| Equity | SEK 286K | +16% |
| Employees | 2 | — |
Legal name
Emmer Medical AB
Org number
5594178203
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 januari 2023
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall direkt eller genom dotterbolag bedriva konsultverksamhet inom hälso- och sjukvård, friskvård, forskning, laboratorieverksamhet kopplad till hälso- och sjukvård eller medicinsk forskning, samt utbildning. Därtill bemanning och uthyrning av vårdpersonal, samt därmed förenlig verksamhet. Bolaget skall direkt eller indirekt äga, underhålla och förvalta fastigheter, uthyrning av fastigheter, samt köpa och förvalta aktier och andra värdepapper, samt därmed förenlig verksamhet.
Address
Birger Jarlsgatan 125 Lgh 1302
Email
emmer.medical@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 153 | 419 | 412 |
| Staff expenses | — | — | — |
| EBITDA | 111 | 274 | 328 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 111 | 274 | 328 |
| Net financials | — | 4 | 2 |
| Profit before tax | 111 | 278 | 330 |
| Tax | −23 | −58 | −69 |
| Net profit | 88 | 220 | 261 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 193 | 426 | 681 |
| Equity | 113 | 246 | 286 |
| Long-term debt | 0 | 0 | 100 |
| Short-term debt | 80 | 180 | 294 |
| Total debt | 80 | 180 | 394 |
EBITDA margin
79.6%
This company
15.8%
Market median
+404% vs market
20232025
Equity ratio
42.0%
This company
38.2%
Market median
+10% vs market
20232025
Return on equity
91.3%
This company
18.4%
Market median
+396% vs market
20232025
Net profit margin
63.3%
This company
8.1%
Market median
+681% vs market
20232025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20232025
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Deputy Board Member | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emmer Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rony Emmer | Board of Directors | 0 companies |
| Fanny Solveig Karin Emmer | Chairman | 0 companies |
| Eva Kristina Östman | Deputy Board Member | 0 companies |